In terms of the requirements of Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that the Company has issued letters to those Shareholder’s whose e-mail addresses are not registered with the Company/Depository Participants, providing the weblink from where the Annual Report can be accessed on the Company’s website. The letter in this regard is enclosed.
The above information is a part of company’s filings submitted to BSE.
